BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3056548)

  • 1. Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.
    Lum LG; Noges JE; Beatty P; Martin PJ; Deeg J; Doney KC; Loughran T; Sullivan KM; Witherspoon RP; Thomas ED
    Bone Marrow Transplant; 1988 Sep; 3(5):399-406. PubMed ID: 3056548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptively transferred immunity persists in human marrow graft recipients.
    Lum LG; Seigneuret MC; Shiobara S; Noges J; Munn N; Shough N; Jin NR; Beatty P; Martin P; Sullivan K
    Prog Clin Biol Res; 1987; 244():449-60. PubMed ID: 2821549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of specific antibody formation to recall antigens after human bone marrow transplantation.
    Lum LG; Munn NA; Schanfield MS; Storb R
    Blood; 1986 Mar; 67(3):582-7. PubMed ID: 3511982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
    Shiobara S; Lum LG; Witherspoon RP; Storb R
    Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrow.
    Chaushu S; Chaushu G; Garfunkel A; Slavin S; Or R; Yefenof E
    Bone Marrow Transplant; 1994 Dec; 14(6):925-8. PubMed ID: 7711670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.
    Bosserman LD; Murray C; Takvorian T; Anderson KC; Freedman AS; Fitzsimmons J; Coral F; Nadler LM; Schlossman SF; Ritz J
    Bone Marrow Transplant; 1989 May; 4(3):239-45. PubMed ID: 2659109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell development and regulation after T cell-depleted marrow transplantation.
    Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
    J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.
    Benkerrou M; Wara DW; Elder M; Dror Y; Merino A; Colombe BW; Garovoy M; Cowan MJ
    J Clin Immunol; 1994 Mar; 14(2):98-106. PubMed ID: 8195318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
    Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
    Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.
    Lum LG; Seigneuret MC; Storb R
    J Clin Immunol; 1986 Sep; 6(5):389-96. PubMed ID: 2429980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
    Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
    Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.